![William W. Freimuth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
William W.
Freimuth worked as a Clinical Director-Therapeutic Area at Pharmacia & Upjohn, Inc. and as a VP-Clinical Research, Immunology & Rheumatology at Human Genome Sciences, Inc. He holds a doctorate degree from Michigan State University and State University of New York at Buffalo, and an undergraduate degree from the University of Michigan.
Precedenti posizioni note di William W. Freimuth
Società | Posizione | Fine |
---|---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Direttore Tecnico/Scientifico/R&S | 22/08/2011 |
Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
Formazione di William W. Freimuth
State University of New York at Buffalo | Doctorate Degree |
Michigan State University | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Pharmacia & Upjohn, Inc. | Health Technology |
- Borsa valori
- Insiders
- William W. Freimuth